Literature DB >> 203508

The metabolic fate of high density lipoprotein (HDL) in the diabetic rat.

H Bar-On, S Eisenberg.   

Abstract

Diabetic rats, pre-fed and maintained on a sucrose-rich diet, have marked hyperlipoproteinaemia, with an increase in both very low density (VLDL) and high density lipoproteins (HDL). HDL obtained from both diabetic and non-diabetic rats and labelled with 125I or 135I was injected simultaneously into diabetic and non-diabetic rats. The half life of the two HDL preparations was similar in both diabetic and non-diabetic rats and ranged between 11.4 to 12.0 hours. A-I apolipoprotein had a disappearance rate parallel to the whole HDL, in contrast to the apo-C peptides which had a faster rate of removal. Although the fractional catabolic rate (FCR) of HDL preparations was slower in the diabetic rats, there was a 16% increase in the calculated synthetic rate (SR) of HDL-protein. These observations could explain the increased plasma HDL levels in the sucrose-fed, streptozotocin-induced diabetic rat.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 203508     DOI: 10.1007/bf00429710

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  12 in total

1.  The effect of acute insulin deficiency in the rat on adipose tissue lipolytic activity and plasma lipids.

Authors:  J D SCHNATZ; R H WILLIAMS
Journal:  Diabetes       Date:  1963 Mar-Apr       Impact factor: 9.461

2.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

3.  Efficient trace-labelling of proteins with iodine.

Authors:  A S McFARLANE
Journal:  Nature       Date:  1958-07-05       Impact factor: 49.962

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Metabolism of iodinated high density lipoproteins in the rat. I. Half-life in the circulation and uptake by organs.

Authors:  P S Roheim; D Rachmilewitz; O Stein; Y Stein
Journal:  Biochim Biophys Acta       Date:  1971-11-05

6.  Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.

Authors:  H Bar-On; P S Roheim; H A Eder
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

7.  Hyperlipemia and diabetes mellitus.

Authors:  E L Bierman; J A Amaral; B H Belknap
Journal:  Diabetes       Date:  1966-09       Impact factor: 9.461

8.  Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans.

Authors:  T Sata; R J Havel; A L Jones
Journal:  J Lipid Res       Date:  1972-11       Impact factor: 5.922

9.  Hypertriglyceridemia in the diabetic rat. Defective removal of serum very low density.

Authors:  A Van Tol
Journal:  Atherosclerosis       Date:  1977-01       Impact factor: 5.162

10.  Hyperlipoproteinemia in streptozotocin-treated rats.

Authors:  H Bar-On; P S Roheim; H A Eder
Journal:  Diabetes       Date:  1976-06       Impact factor: 9.461

View more
  4 in total

1.  Metabolic fate of sphingomyelin of high-density lipoprotein in rat plasma.

Authors:  M Bentejac; M Bugaut; M C Delachambre; J Lecerf
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

2.  Catabolism of very low density lipoproteins in experimental nephrosis.

Authors:  D W Garber; B A Gottlieb; J B Marsh; C E Sparks
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

3.  Lipoprotein secretion by isolated perfused livers from streptozotocin-diabetic rats.

Authors:  E M Berry; E Ziv; H Bar-On
Journal:  Diabetologia       Date:  1981-10       Impact factor: 10.122

4.  Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.

Authors:  S Van Linthout; A Riad; N Dhayat; F Spillmann; J Du; S Dhayat; D Westermann; D Hilfiker-Kleiner; M Noutsias; U Laufs; H-P Schultheiss; C Tschöpe
Journal:  Diabetologia       Date:  2007-06-23       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.